CCX140 NEW
| Price | $50 | $62 | $92 |
| Package | 2mg | 5mg | 10mg |
| Supply Ability: | 10g |
| Update Time: | 2026-05-11 |
Product Details
| Product Name: CCX140 | CAS No.: 1100318-47-5 |
| Purity: 99.66% | Supply Ability: 10g |
| Release date: 2026/05/11 |
Product Introduction
Bioactivity
| Name | CCX140 |
| Description | CCX140 (CCX140-B) (CCX140-B) is an antagonist of CCR2. |
| In vitro | CCX140 inhibits the binding of 125I-CCL2 to monocytes with an IC50 value of 17 nM and it also inhibits CCL2-induced Ca2+ mobilization in monocytes with an IC50 value of 3 nM. CCX140 (CCX140-B) potently inhibits CCL2-induced chemotaxis of purified human blood monocytes with IC50 values of 8 nM in buffer and 200 nM in the presence of 100% human serum. CCX140 has a Kd value of 2.3 nM toward hCCR2. CCX140 also inhibits monocyte chemotaxis mediated by the other CCR2 ligands: CCL8/MCP-2, CCL7/MCP-3, and CCL13/MCP-4[1]. |
| In vivo | CCX140 effectively moderates various metabolic and immunological parameters. It decreases urine and glucose excretion, lowers hepatic glycogen and triglyceride contents, and reduces glucose 6-phosphatase levels. In hCCR2 KI mice, CCX140-B dosage exhibits a significant, dose-dependent capability to mitigate peritoneal leukocyte count following thioglycollate induction, displaying robust leukocyte infiltration inhibition at 30 mg/kg, partial inhibition at 10 mg/kg, and no effect at 3 mg/kg. Additionally, in diet-induced obese (DIO) mice, CCX140 acts as a CCR2 antagonist, fully preventing inflammatory macrophage recruitment to visceral adipose tissue. For DIO hCCR2 KI mice treated with 100 mg/kg of CCX140, there's an evident halt in the escalating urine albumin excretion rate (UAER) and albumin to creatinine ratio (ACR), with sustained lower levels throughout an 8-week dosage period. The treated mice also show reduced hyperglycemia and insulin levels, enhanced insulin sensitivity, escalated circulating adiponectin levels, diminished pancreatic islet size, and an increase in islet number, demonstrating CCX140's comprehensive therapeutic potential. |
| Storage | Keep away from direct sunlight Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O : 0.25 mg/mL (0.5 mM), Sonication and heating are recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 4 mg/mL (8.07 mM), Sonication is recommended. DMSO : 100 mg/mL (201.67 mM), Sonication is recommended. |
| Keywords | hCCR2 | CCX-140 | CCX140 | CCX 140 | CCR5 | CCR2 |
| Inhibitors Related | AZD2098 | MLN-3897 TFA | Artemotil | CCR2 antagonist 5 | INCB-9471 | Maraviroc | BMS-817399 | Ancriviroc | Pirfenidone | Vercirnon | PNU-177864 | CCR6 antagonist 1 |
| Related Compound Libraries | Failed Clinical Trials Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Chemokine Inhibitor Library | Drug Repurposing Compound Library | Inhibitor Library | Immunology/Inflammation Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | Fluorochemical Library | Covalent Inhibitor Library | GPCR Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $50.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-05-11 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY